Filana Therapeutics's total assets for Q2 2026 were $103.90M, a decrease of -12.21% from the previous quarter. MX:FLNA total liabilities were $40.29M for the fiscal quarter, a -8.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.